Neurogenic components of trypsin- and thrombin-induced inflammation in rat skin, in vivo

Experimental Dermatology

Volumn 15, Issue 1, 2006, Pages 58-65

  Obreja, Otilia ^a,b   Rukwied, Roman ^a   Steinhoff, Martin ^c   Schmelz, Martin ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Dermal microdialysis; Neuropeptide receptors; Neuropeptides; Protease activated receptors; Proteases

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; NOLPITANTIUM; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; SUBSTANCE P ANTAGONIST; SUBSTANCE P RECEPTOR; THROMBIN; TRYPSIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE (8 37); CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE-RELATED PEPTIDE (8-37); NEUROKININ 1 RECEPTOR; PEPTIDE FRAGMENT; PIPERIDINE DERIVATIVE; PROTEINASE ACTIVATED RECEPTOR; QUINUCLIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; DIALYSATE; IN VIVO STUDY; LASER DOPPLER FLOWMETRY; MALE; MICRODIALYSIS; NOCICEPTIVE RECEPTOR; NONHUMAN; PATHOGENESIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; RAT STRAIN; RECEPTOR BLOCKING; SKIN INFLAMMATION; VASODILATATION; ANIMAL; CAPILLARY PERMEABILITY; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; INFLAMMATION; NEUROGENIC INFLAMMATION; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN; WISTAR RAT;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CAPILLARY PERMEABILITY; INFLAMMATION; MALE; NEUROGENIC INFLAMMATION; PEPTIDE FRAGMENTS; PIPERIDINES; QUINUCLIDINES; RATS; RATS, WISTAR; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; RECEPTORS, NEUROKININ-1; RECEPTORS, PROTEINASE-ACTIVATED; SKIN; THROMBIN; TRYPSIN; VASODILATION;

EID: 33644873961     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2005.00392.x     Document Type: Article

References (60)

1. Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 1994: 91: 9208-9212.
2. Vu T K, Hung D T, Wheaton V I, Coughlin S R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991: 64: 1057-1068.
3. Dery O, Corvera C U, Steinhoff M, Bunnett N W. Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases. Am J Physiol 1998: 274: C1429-C1452.
4. Steinhoff M, Buddenkotte J, Shpacovitch V et al. Proteinase-activated receptors: Transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 2005: 26: 1-43.
5. Vergnolle N, Ferazzini M, D'Andrea M R, Buddenkotte J, Steinhoff M. Proteinase-activated receptors: Novel signals for peripheral nerves. Trends Neurosci 2003: 26: 496-500.
6. Steinhoff M, Vergnolle N, Young S H et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000: 6: 151-158.
7. Kawabata A, Kawao N, Kuroda R, Tanaka A, Itoh H, Nishikawa H. Peripheral PAR-2 triggers thermal hyperalgesia and nociceptive responses in rats. Neuroreport 2001: 12: 715-719.
8. de Garavilla L, Vergnolle N, Young S H et al. Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism. Br J Pharmacol 2001: 133: 975-987.
9. Zhu W J, Yamanaka H, Obata K et al. Expression of mRNA for four subtypes of the proteinase-activated receptor in rat dorsal root ganglia. Brain Res 2005: 1041: 205-211.
10. Klarenbach S W, Chipiuk A, Nelson R C, Hollenberg M D, Murray A G. Differential actions of PAR2 and PAR1 in stimulating human endothelial cell exocytosis and permeability: The role of Rho-GTPases. Circ Res 2003: 92: 272-278.
11. Cenac N, Garcia-Villar R, Ferrier L et al. Proteinase-activated receptor-2-induced colonic inflammation in mice: Possible involvement of afferent neurons, nitric oxide, and paracellular permeability. J Immunol 2003: 170: 4296-4300.
12. Seeliger S, Derian C K, Vergnolle N et al. Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo. FASEB J 2003: 17: 1871-1885.
13. Shpacovitch V M, Brzoska T, Buddenkotte J et al. Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells. J Invest Dermatol 2002: 118: 380-385.
14. Steinhoff M, Corvera C U, Thoma M S et al. Proteinase-activated receptor-2 in human skin: Tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 1999: 8: 282-294.
15. Steinhoff M, Neisius U, Ikoma A et al. Proteinase-activated receptor-2 mediates itch: A novel pathway for pruritus in human skin. J Neurosci 2003: 23: 6176-6180.
16. Buckingham K W, Berg R W. Etiologic factors in diaper dermatitis: The role of feces. Pediatr Dermatol 1986: 3: 107-112.
17. Andersen P H, Bucher A P, Saeed I, Lee P C, Davis J A, Maibach H I. Faecal enzymes: In vivo human skin irritation. Contact Dermatitis 1994: 30: 152-158.
18. Bjelland S, Hjelmeland K, Volden G. Degradation of human epidermal keratin by cod trypsin and extracts of fish intestines. Arch Dermatol Res 1989: 280: 469-473.
19. Sorsa T, Salo T, Koivunen E et al. Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem 1997: 272: 21067-21074
20. Alm A K, Gagnemo-Persson R, Sorsa T, Sundelin J. Extrapancreatic trypsin-2 cleaves proteinase-activated receptor-2. Biochem Biophys Res Commun 2000: 275: 77-83.
21. Babiarz-Magee L, Chen N, Seiberg M, Lin C B. The expression and activation of protease-activated receptor-2 correlate with skin color. Pigment Cell Res 2004: 17: 241-251.
22. Meyer-Hoffert U, Rogalski C, Seifert S et al. Trypsin induces epidermal proliferation and inflammation in murine skin. Exp Dermatol 2004: 13: 234-241.
23. Cocks T M, Moffatt J D. Protease-activated receptors: Sentries for inflammation? Trends Pharmacol Sci 2000: 21: 103-108.
24. Sauerstein K, Klede M, Hilliges M, Schmelz M. Electrically evoked neuropeptide release and neurogenic inflammation differ between rat and human skin. J Physiol 2000: 529 (Pt 3): 803-810.
25. Obreja O, Schmelz M, Poole S, Kress M. Interleukin-6 in combination with its soluble IL-6 receptor sensitises rat skin nociceptors to heat, in vivo. Pain 2002: 96: 57-62.
26. Schmelz M, Luz O, Averbeck B, Bickel A. Plasma extravasation and neuropeptide release in human skin as measured by intradermal microdialysis. Neurosci Lett 1997: 230: 117-120.
27. Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976: 72: 248-254.
28. Weidner C, Klede M, Rukwied R et al. Acute effects of substance P and calcitonin gene-related peptide in human skin -a microdialysis study. J Invest Dermatol 2000: 115: 1015-1020.
29. Xu W F, Andersen H, Whitmore T E et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 1998: 95: 6642-6646.
30. Cottrell G S, Amadesi S, Grady E F, Bunnett N W. Trypsin IV, a novel agonist of protease-activated receptors 2 and 4. J Biol Chem 2004: 279: 13532-13539.
31. Koshikawa N, Hasegawa S, Nagashima Y et al. Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse. Am J Pathol 1998: 153: 937-944.
32. Hou L, Kapas S, Cruchley A T et al. Immunolocalization of protease-activated receptor-2 in skin: Receptor activation stimulates interleukin-8 secretion by keratinocytes in vitro. Immunology 1998: 94: 356-362.
33. Holzer P. Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol 1998: 30: 5-11.
34. Emonds-Alt X, Doutremepuich J D, Heaulme M et al. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur J Pharmacol 1993: 250: 403-413.
35. Dennis T, Fournier A, Cadieux A et al. hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther 1990: 254: 123-128.
36. Vergnolle N, Hollenberg M D, Sharkey K A, Wallace J L. Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Br J Pharmacol 1999: 127: 1083-1090
37. Brain S D, Williams T J. Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature 1988: 335: 73-75.
38. Zhao W, Oskeritzian C A, Pozez A L, Schwartz L B. Cytokine production by skin-derived mast cells: Endogenous proteases are responsible for degradation of cytokines. J Immunol 2005: 175: 2635-2642.
39. Feletou M, Bonnardel E, Canet E. Bradykinin and changes in microvascular permeability in the hamster cheek pouch: Role of nitric oxide. Br J Pharmacol 1996: 118: 1371-1376
40. Kawabata A, Kawao N, Itoh H et al. Role of N-methyl-D-aspartate receptors and the nitric oxide pathway in nociception/hyperalgesia elicited by protease-activated receptor-2 activation in mice and rats. Neurosci Lett 2002: 329: 349-353.
41. Amadesi S, Nie J, Vergnolle N et al. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci 2004: 24: 4300-4312.
42. Kawabata A, Kinoshita M, Kuroda R, Kakehi K. Capsazepine partially inhibits neurally mediated gastric mucus secretion following activation of protease-activated receptor 2. Clin Exp Pharmacol Physiol 2002: 29: 360 -361.
43. Kawabata A, Itoh H, Kawao N et al. Activation of trigeminal nociceptive neurons by parotid PAR-2 activation in rats. Neuroreport 2004: 15: 1617-1621.
44. Dai Y, Moriyama T, Higashi T et al. Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J Neurosci 2004: 24: 4293-4299.
45. Coelho A M, Vergnolle N, Guiard B, Fioramonti J, Bueno L. Proteinases and proteinase-activated receptor 2: A possible role to promote visceral hyperalgesia in rats. Gastroenterology 2002: 122: 1035-1047.
46. Hoogerwerf W A, Zou L, Shenoy M et al. The proteinase-activated receptor 2 is involved in nociception. J Neurosci 2001: 21: 9036-9042.
47. Carr M J, Schechter N M, Undem B J. Trypsin-induced, neurokinin-mediated contraction of guinea pig bronchus. Am J Respir Crit Care Med 2000: 162: 1662-1667.
48. Schmelz M, Zeck S, Raithel M, Rukwied R. Mast cell tryptase in dermal neurogenic inflammation. Clin Exp Allergy 1999: 29: 695-702.
49. Rao C N, Peavey C L, Liu Y Y, Lapiere J C, Woodley D T. Partial characterization of matrix-associated serine protease inhibitors from human skin cells. J Invest Dermatol 1995: 104: 379-383.
50. Rao C N, Liu Y Y, Peavey C L, Woodley D T. Novel extracellular matrix-associated serine proteinase inhibitors from human skin fibroblasts. Arch Biochem Biophys 1995: 317: 311-314.
51. Wang H, Ubl J J, Reiser G. Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Glia 2002: 37: 53-63.
52. Niclou S P, Suidan H S, Pavlik A, Vejsada R, Monard D. Changes in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesion. Eur J Neurosci 1998: 10: 1590-1607.
53. D'Andrea M R, Saban M R, Nguyen N B, Andrade-Gordon P, Saban R. Expression of protease-activated receptor-1-2-3, and -4 in control and experimentally inflamed mouse bladder. Am J Pathol 2003: 162: 907-923.
54. Vergnolle N, Hollenberg M D, Wallace J L. Pro- and anti-inflammatory actions of thrombin: A distinct role for proteinase-activated receptor-1 (PAR1). Br J Pharmacol 1999: 126: 1262-1268.
55. Kawabata A, Kawao N, Kuroda R, Tanaka A, Shimada C. The PAR-1-activating peptide attenuates carrageenan-induced hyperalgesia in rats. Peptides 2002: 23: 1181-1183.
56. Asfaha S, Brussee V, Chapman K, Zochodne D W, Vergnolle N. Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli. Br J Pharmacol 2002: 135: 1101-1106.
57. Algermissen B, Sitzmann J, Nurnberg W, Laubscher J C, Henz B M, Bauer F. Distribution and potential biologic function of the thrombin receptor PAR-1 on human keratinocytes. Arch Dermatol Res 2000: 292: 488-495.
58. D'Andrea M R, Rogahn C J, Andrade-Gordon P. Localization of protease-activated receptors-1 and -2 in human mast cells: Indications for an amplified mast cell degranulation cascade. Biotech Histochem 2000: 75: 85-90.
59. Vouret-Craviari V, Grall D, Obberghen-Schilling E. Modulation of Rho GTPase activity in endothelial cells by selective proteinase-activated receptor (PAR) agonists. J Thromb Haemost 2003: 1: 1103-1111.
60. Nakanishi-Matsui M, Zheng Y W, Sulciner D J, Weiss E J, Ludeman M J, Coughlin S R. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 2000: 404: 609-613.